THE MIRADRY TREATMENT: THE BEST MEDICAL CARE FOR EXCESSIVE SWEATING, AVAILABLE AT THE CLIPP – PARIS

Excessive sweating located on the armpits is commonly labelled as “Hyperhydrosis”.  Being the cause of discomfort and inconvenience for both Men and Women, this affection is very often under-estimated and can be very embarrassing. Until now, this issue was inadequately handled in terms of medical care…

• Iontophoresis devices could be proposed to the patients, but the results are non-lasting on the hands and disappointing concerning armpits.

• Botulinic Toxin (Botox) was eventually an alternative but needs to be performed regularly because of its non-lasting effect on the treated area. Moreover, it generally necessitates the use of at least two bottles.

For some years now in the USA, a revolutionary device came up, electively targeting sweat glands through a thermal mechanism resulting in their destruction:  the MIRADRY short-waves. Sweating is simply eradicated from your everyday life, in a durable way.

Because sweat glands are completely destroyed during one (or maximum two treatment sessions) and don’t tend to regenerate (they do only emerge through the foetal phase), clinical results proved the effectiveness of MIRADRY, as well as its permanent character.

Nowadays, the FDA gave the following “permanent reduction of transpiration” denomination to the MiraDry device, thanks to years of clinical studies and improvements.

Our patients beneficiate form durable, permanent results, drastically reducing sweat, after one single treatment session for most patients. Most severe cases can potentially receive two treatment sessions. The CLIPP is proud to be amongst the very firsts in Europe to propose our patients this revolutionary device.

Performed by renowned and trained physicians, MiraDry  is very safe with no down-time.

In any cases, a prior consultation with one of our physicians at the CLIPP is necessary to determine the very best treatment protocol in terms of effectiveness and safety, corresponding to your medical expectations.